11.95
1.96%
0.23
Dopo l'orario di chiusura:
11.95
Precedente Chiudi:
$11.72
Aprire:
$11.7
Volume 24 ore:
209.98K
Relative Volume:
0.79
Capitalizzazione di mercato:
$443.70M
Reddito:
-
Utile/perdita netta:
$-63.78M
Rapporto P/E:
-4.459
EPS:
-2.68
Flusso di cassa netto:
$-53.91M
1 W Prestazione:
+4.64%
1M Prestazione:
-8.71%
6M Prestazione:
-34.81%
1 anno Prestazione:
-20.86%
Celcuity Inc Stock (CELC) Company Profile
Nome
Celcuity Inc
Settore
Industria
Telefono
763-392-0767
Indirizzo
16305 36TH AVENUE N, MINNEAPOLIS, MN
Confronta CELC con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
CELC
Celcuity Inc
|
11.95 | 443.70M | 0 | -63.78M | -53.91M | -2.68 |
VRTX
Vertex Pharmaceuticals Inc
|
461.68 | 118.90B | 10.63B | -479.80M | -1.35B | -1.99 |
REGN
Regeneron Pharmaceuticals Inc
|
672.98 | 73.95B | 13.85B | 4.65B | 3.32B | 40.41 |
ARGX
Argen X Se Adr
|
655.13 | 39.81B | 1.86B | -40.29M | -1.28B | -0.85 |
ALNY
Alnylam Pharmaceuticals Inc
|
271.31 | 34.99B | 2.09B | -332.26M | 16.06M | -2.62 |
BNTX
Biontech Se Adr
|
123.77 | 29.67B | 3.30B | -501.07M | 1.03B | -2.1146 |
Celcuity Inc Stock (CELC) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-07-22 | Iniziato | Leerink Partners | Outperform |
2024-02-22 | Iniziato | Stifel | Buy |
2023-12-08 | Iniziato | H.C. Wainwright | Buy |
2021-10-08 | Iniziato | Canaccord Genuity | Buy |
2021-09-07 | Iniziato | Jefferies | Buy |
2021-07-29 | Iniziato | Cowen | Outperform |
2021-07-27 | Iniziato | Needham | Buy |
2021-01-28 | Reiterato | H.C. Wainwright | Buy |
2020-12-24 | Reiterato | H.C. Wainwright | Buy |
2020-05-11 | Ripresa | Craig Hallum | Buy |
2018-11-20 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Celcuity Inc Borsa (CELC) Ultime notizie
When (CELC) Moves Investors should Listen - Stock Traders Daily
Jefferies lifts Celcuity stock target to $33, maintains Buy rating - MSN
Jefferies lifts Celcuity stock target to $33, maintains Buy rating By Investing.com - Investing.com Australia
Hennion & Walsh Asset Management Inc. Buys 71,006 Shares of Celcuity Inc. (NASDAQ:CELC) - MarketBeat
Celcuity Inc. (NASDAQ:CELC) Receives $29.17 Average PT from Analysts - Defense World
Celcuity Inc. (NASDAQ:CELC) Holdings Raised by Barclays PLC - Defense World
Celcuity Inc. (NASDAQ:CELC) Shares Bought by Barclays PLC - MarketBeat
Celcuity Inc. (NASDAQ:CELC) Receives $29.17 Average PT from Brokerages - MarketBeat
Analyzing Celcuity (NASDAQ:CELC) and CannLabs (OTCMKTS:CANL) - Defense World
Jane Street Group LLC Sells 9,921 Shares of Celcuity Inc. (NASDAQ:CELC) - Defense World
Celcuity stock touches 52-week low at $11.51 amid market challenges - Investing.com Australia
Objective long/short (CELC) Report - Stock Traders Daily
Geode Capital Management LLC Acquires 136,518 Shares of Celcuity Inc. (NASDAQ:CELC) - MarketBeat
Celcuity Inc. (NASDAQ:CELC) Shares Purchased by Geode Capital Management LLC - Defense World
Celcuity Inc. (NASDAQ:CELC) Shares Acquired by Barclays PLC - Defense World
Barclays PLC Raises Stock Position in Celcuity Inc. (NASDAQ:CELC) - MarketBeat
Celcuity (NASDAQ:CELC) Trading Up 3.8%Here's Why - MarketBeat
State Street Corp Purchases 668,318 Shares of Celcuity Inc. (NASDAQ:CELC) - MarketBeat
How to Take Advantage of moves in (CELC) - Stock Traders Daily
Celcuity Inc. (NASDAQ:CELC) Receives $29.17 Consensus Target Price from Analysts - Defense World
Celcuity Inc. (NASDAQ:CELC) Given Average Rating of "Buy" by Analysts - MarketBeat
Wellington Management Group LLP Makes New Investment in Celcuity Inc. (NASDAQ:CELC) - MarketBeat
Mama's Creations Posts Weak Earnings, Joins EVgo, Red Cat Holdings And Other Big Stocks Moving Lower In Tuesday's Pre-Market SessionCelcuity (NASDAQ:CELC), Apellis Pharmaceuticals (NASDAQ:APLS) - Benzinga
Celcuity (CELC) Charges Forward with Promising Potential Cancer Treatments - TipRanks
Celcuity Inc. (NASDAQ:CELC) Short Interest Update - MarketBeat
Charles Schwab Investment Management Inc. Purchases 153,712 Shares of Celcuity Inc. (NASDAQ:CELC) - Defense World
(CELC) Investment Report - Stock Traders Daily
BNP Paribas Financial Markets Raises Holdings in Celcuity Inc. (NASDAQ:CELC) - MarketBeat
BNP Paribas Financial Markets Has $673,000 Stake in Celcuity Inc. (NASDAQ:CELC) - Defense World
Celcuity reports survival data for breast cancer drug - Investing.com
Celcuity Presents Overall Survival Data from Phase 1b Study Evaluating Gedatolisib in Combination with Palbociclib and Endocrine Therapy at the 2024 San Antonio Breast Cancer Symposium - The Manila Times
Celcuity Presents Overall Survival Data from Phase 1b Study - GlobeNewswire
Verition Fund Management LLC Reduces Holdings in Celcuity Inc. (NASDAQ:CELC) - MarketBeat
Braidwell LP Buys 367,663 Shares of Celcuity Inc. (NASDAQ:CELC) - MarketBeat
Celcuity Inc. (NASDAQ:CELC) Given Consensus Rating of "Buy" by Brokerages - MarketBeat
(CELC) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Celcuity’s (CELC) “Buy” Rating Reiterated at Needham & Company LLC - Defense World
Celcuity’s (CELC) “Buy” Rating Reiterated at HC Wainwright - Defense World
Celcuity (NASDAQ:CELC) Receives "Buy" Rating from HC Wainwright - MarketBeat
Celcuity stock hits 52-week low at $12.14 amid market shifts - Investing.com
500: Something went wrong - Investing.com India
Earnings call: Celcuity reports Q3 2024 financials and clinical trial updates - Investing.com
Celcuity's (CELC) Buy Rating Reaffirmed at Needham & Company LLC - MarketBeat
Celcuity Inc. (NASDAQ:CELC) Q3 2024 Earnings Call Transcript - Insider Monkey
RA Capital Management, L.P. Acquires New Stake in Celcuity Inc - GuruFocus.com
COMMODORE CAPITAL LP's Strategic Acquisition of Celcuity Inc Sha - GuruFocus.com
Celcuity Inc (CELC) Q3 2024 Earnings Call Highlights: Clinical Milestones and Financial Challenges By GuruFocus - Investing.com Canada
Celcuity Inc. Reports Q3 Progress and Financials - TipRanks
Celcuity Inc Azioni (CELC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):